Lv1
40 积分 2025-06-18 加入
Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity
1个月前
已完结
Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis
1个月前
已完结
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
1个月前
已完结
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
4个月前
已完结
Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment
4个月前
已完结
Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes
4个月前
已完结
Bone resorption is unchanged by liraglutide in type 2 diabetes patients: A randomised controlled trial
4个月前
已完结
Safety and efficacy of GLP-1/FGF21 dual agonist HEC88473 in MASLD and T2DM: A randomized, double-blind, placebo-controlled study
5个月前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
5个月前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
5个月前
已完结
皖公网安备34019202002308
